Harold Bernstein

President, R&D & CMO

Harold Bernstein (President, R&D & CMO) filed 14 Form 4 reports in the trailing twelve months (0 purchases, 14 sales), most often in Maze Therapeutics, Inc. (MAZE). The largest single filing was $1.8M of MAZE (45,000 sh across 2 lots, as filed), executed Dec 29 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 14 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$8.8M

shares × price, as filed

Last traded

Sep 4

Filed Sep 8

Median ADV $16.9M across their filed names

Open performance→

Volume by month

Buys $0 Sells $8.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 14 filings

Sector per market data · by filing · past 12 months

Most traded names

MAZE

Maze Therapeutics, Inc. MAZE · 0 buys · 14 sells 14 filings

Recent filings

MAZESALE Maze Therapeutics, Inc. View filing → $255K
9,705 sh × $26.22
Exec Sep 4
Filed Sep 8 · 4:20 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $252K
9,611 sh across 2 lots
Exec Sep 2
Filed Sep 4 · 4:22 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $426K
16,141 sh × $26.36
Exec Sep 1
Filed Sep 3 · 4:24 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $446K
16,142 sh × $27.61
Exec Aug 13
Filed Aug 14 · 4:54 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $400K
13,409 sh × $29.86
Exec Jul 1
Filed Jul 2 · 4:29 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $339K
13,253 sh × $25.57
Exec Jun 1
Filed Jun 3 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $393K
15,000 sh × $26.22
Exec May 14
Filed May 18 · 5:30 PM ET MAZESALE Maze Therapeutics, Inc. View filing → $433K
14,700 sh across 2 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET More filings →